Further investigation into the regulation of the SIRT5/p53 axis by LEVs on the proliferation and glycolytic metabolism of colon cancer cells revealed a study indicating an association between GLU-1 expression levels and glucose metabolism (Meng et al. 2019). Here, TP53 is linked to malignant colon neoplasm.